Ask most people where cinnamon comes from and they'll say Sri Lanka, or just shrug and say "somewhere tropical." Almost nobody says Indonesia — and yet Indonesia is, by volume, the largest cinnamon producer on Earth, supplying roughly 46 percent of the entire global market. Nearly all of it comes from Cinnamomum burmannii, grown mostly on the slopes of Sumatra, in a region historically centered on Kerinci — a name that, filtered through Dutch trading tongues in the 17th century, became "Korintje," which is still the name most commonly printed on cinnamon packaging in American grocery stores today.
The history runs even deeper than the Dutch trade era. Long before European ships found their way to the source, Indonesian sailors reportedly carried cinnamon by raft directly to East Africa along what's sometimes called the "cinnamon route" — a trade so old and so effective at obscuring its true origin that Mediterranean traders spent centuries deliberately keeping cinnamon's actual source a mystery, to protect their monopoly on it.
So: the world's most-produced cinnamon, and one of the oldest spice trade stories in human history — coming from a plant most people can't correctly name.
One word covering four different trees
Here's what "cinnamon" actually hides: it's not one species. Ceylon cinnamon (Cinnamomum verum, "true cinnamon") comes from Sri Lanka. Chinese cinnamon (C. cassia) comes from China. Saigon cinnamon (C. loureiroi) comes from Vietnam. And Indonesian cinnamon (C. burmannii) comes from Sumatra. All four get sold, labeled, and cooked with as "cinnamon," interchangeably, by people who have no way of knowing which tree their spice jar actually came from.
That's unusual even by this project's standards. Betel leaf and areca nut at least come wrapped together, visibly, as two separate things. "Cinnamon" collapses four separate species into one word at the grocery store level — and as the next two sections show, that collapse isn't trivial. The differences between these trees aren't just about flavor intensity. One of them contains a compound the others carry in genuinely different, regulation-relevant quantities.
Kayu manis, "sweet wood," in its own right
In Javanese traditional medicine, cinnamon bark has long been boiled together with clove and ginger as a remedy for colds and general fatigue — a formula that shows up in various forms throughout Indonesian herbal practice, and one you've already met in a supporting role, since cinnamon appears as an optional addition to wedang jahe in the ginger story earlier in this project.
Commercially, Indonesian cinnamon's story is really a colonial trade story: the Dutch East India Company exported it from Padang, Sumatra, through the 17th century, cementing the plant's place in global trade even as "true cinnamon" from Ceylon carried more prestige in European markets. Today, that historical imbalance in reputation still holds — Ceylon cinnamon is marketed as premium, while Indonesian cinnamon, despite dominating global supply, mostly ends up as the anonymous "cinnamon" on supermarket shelves, its origin unlabeled and unnoticed.
Same flavor compound, very different safety profile
All Cinnamomum species share cinnamaldehyde as their dominant aromatic compound — it's what makes cinnamon smell and taste like cinnamon, regardless of species. If that were the whole story, the species distinction wouldn't matter much.
But cinnamon bark also contains coumarin, a naturally occurring compound with real, well-documented liver toxicity at high doses — and here the species split matters enormously. Ceylon cinnamon contains only trace amounts, often below the detectable limit in lab testing. Cassia-type cinnamons — Chinese, Vietnamese, and Indonesian alike — contain substantially more, commonly in the range of several thousand milligrams per kilogram. Indonesian cinnamon, chemically, is a cassia type. Its celebrated global dominance and its coumarin content are the same fact, viewed from two different angles.
Mixed evidence for benefit, solid evidence for a real caution
Cinnamon's most-marketed claim is blood sugar control, and the evidence here is a genuine case study in how research quality can look very different depending on how closely you scrutinize it. Plenty of individual randomized trials and meta-analyses — including one covering 28 trials and over 3,000 patients — report statistically significant reductions in fasting glucose and HbA1c. But a rigorous 2025 umbrella review, which specifically assessed the methodological quality of 21 separate meta-analyses using a formal quality-grading tool, found that none of the evidence reached even "suggestive" strength — most of it graded "weak" or non-significant once evaluated rigorously, with effects that didn't survive stricter statistical thresholds. Individual studies look convincing. Scrutinized collectively, the confidence drops considerably. Complicating things further: many of these trials don't consistently report which Cinnamomum species was actually used, which — given how chemically different the species are — makes the whole body of evidence harder to interpret cleanly.
The coumarin caution, by contrast, is not mixed or contested — it's a settled regulatory finding. The European Food Safety Authority sets a tolerable daily intake for coumarin at 0.1 milligrams per kilogram of body weight; for a 60-kilogram adult, that's roughly 6 milligrams a day. Germany's Federal Institute for Risk Assessment conducted its own bioavailability research and confirmed that coumarin absorbed from cinnamon itself behaves essentially the same as pure isolated coumarin in the body — closing off the argument that "natural" coumarin in a spice matrix is somehow safer. A teaspoon or two of cassia-type cinnamon, consumed daily, can approach or exceed that tolerable limit, and case reports exist of reversible liver enzyme elevation in people who consumed cassia cinnamon heavily and daily, which resolved after switching to Ceylon.
Worth stating plainly, since this project is rooted in Indonesia: this caution applies directly to kayu manis. It isn't a footnote about some other country's cinnamon.
What we genuinely don't know yet
- Whether cinnamon's blood sugar effect is real but modest and obscured by inconsistent study quality and unspecified species, or genuinely weak once you strip away publication bias and small-trial noise.
- How much of the conflicting research literature on cinnamon's health effects is simply an artifact of treating four chemically distinct species as one interchangeable ingredient.
- Whether typical culinary and jamu-level quantities of Indonesian cinnamon pose a meaningful coumarin risk in practice — the clearest dose-response data concerns concentrated supplements and heavy daily use, not the smaller amounts used in most traditional cooking.
We're comfortable saying: we don't know yet.
This closes the first eight plants of the Rempa project, and cinnamon feels like a fitting place to pause. Almost every story in this set turned out to hinge on the same quiet lesson: a single name — galangal, cinnamon, betel, ginger — rarely describes one settled thing. It usually hides a species, a part, a process, or a context that changes the answer once you actually look.
Kayu manis is, at once, one of the oldest and most successful stories in the global spice trade, and a plant whose everyday, high-dose use deserves a level of care its reputation doesn't usually get. Both of those are true at the same time. That's not a contradiction to resolve — it's the kind of complexity this whole project set out to sit with, rather than simplify away. Every plant has a story. Every molecule has one too. There are more still to explore.